These findings proposed that NEP inhibitors may have a protective effect against AD development through increasing GLP‐1, NPY and substance P. However, NEP inhibitors may be implicated in the pathogenesis of AD through the increment of BK and NPs. The gene discussed is MME; the disease is Alzheimer disease.